• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物治疗精神病前驱期的快速反应:一项病例系列研究的启示。

Rapid response to antipsychotic treatment on psychotic prodrome: implications from a case series.

机构信息

Department of Psychiatry, National Taiwan University Hospital, No. 7 Chung Shan S. Road, Taipei 10002, Taiwan.

出版信息

Psychiatry Clin Neurosci. 2010 Apr;64(2):202-6. doi: 10.1111/j.1440-1819.2010.02070.x.

DOI:10.1111/j.1440-1819.2010.02070.x
PMID:20447014
Abstract

The feasible intervention strategy at the prodromal state of psychosis is under debate. We report nine subjects clinically in a putative prodromal state of psychosis who responded to low-dose aripiprazole within the first week of medication. We conjecture that the pathophysiological processes might be easier to modify by antipsychotics in the prodromal state and we believe a short-term low-dose trial of antipsychotic agents is a convenient option for subjects at ultra high risk of psychosis. We urge specific attention to monitor the dissolution of psychotic-like symptoms carefully in order to have a better understanding of the pathogenesis and pharmacotherapy in the inception of psychosis.

摘要

在精神病前驱期可行的干预策略仍存在争议。我们报告了 9 例处于精神病前驱期的临床患者,他们在用药的第一周内对低剂量阿立哌唑有反应。我们推测在前驱期使用抗精神病药物可能更容易改变病理生理过程,我们相信对于处于精神病超高风险的患者,短期低剂量抗精神病药物试验是一种方便的选择。我们强烈建议特别注意监测类精神病症状的缓解情况,以便更好地了解精神病发病机制和药物治疗。

相似文献

1
Rapid response to antipsychotic treatment on psychotic prodrome: implications from a case series.抗精神病药物治疗精神病前驱期的快速反应:一项病例系列研究的启示。
Psychiatry Clin Neurosci. 2010 Apr;64(2):202-6. doi: 10.1111/j.1440-1819.2010.02070.x.
2
Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental state.阿立哌唑对处于高危精神状态个体的洞察力和主观体验的影响。
J Clin Psychopharmacol. 2009 Oct;29(5):421-5. doi: 10.1097/JCP.0b013e3181b2fe22.
3
Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study.阿立哌唑治疗精神病前驱期:一项开放标签的试点研究。
Br J Psychiatry Suppl. 2007 Dec;51:s96-101. doi: 10.1192/bjp.191.51.s96.
4
Supersensitivity psychosis after tapering aripiprazole: a case report.阿立哌唑减量后超敏性精神病:一例报告
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):388-9. doi: 10.1016/j.pnpbp.2008.12.023. Epub 2009 Jan 8.
5
Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.首发精神病患者第二代抗精神病药早期干预:一项 8 周自然研究的结果。
Early Interv Psychiatry. 2010 Feb;4(1):57-63. doi: 10.1111/j.1751-7893.2010.00163.x.
6
Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.阿立哌唑治疗超高危状态和首发精神病的药物初治或抗精神病药短暴露受试者:一项开放标签研究。
J Clin Psychopharmacol. 2013 Feb;33(1):18-23. doi: 10.1097/JCP.0b013e31827cb017.
7
Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.在急诊精神科环境中使用阿立哌唑治疗精神障碍
Psychiatr Danub. 2008 Sep;20(3):323-8.
8
Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.阿立哌唑治疗患有阿尔茨海默病痴呆的机构化患者的精神病:三种固定剂量的多中心、随机、双盲、安慰剂对照评估
Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31. doi: 10.1097/JGP.0b013e3181557b47.
9
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.开放标签灵活剂量试点研究,以评估阿立哌唑在帕金森病相关精神病患者中的安全性和耐受性。
Mov Disord. 2006 Dec;21(12):2078-81. doi: 10.1002/mds.21091.
10
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.阿立哌唑,一种具有新型作用机制的抗精神病药物,与利培酮相比,用于治疗精神分裂症和分裂情感性障碍患者时对照安慰剂。
Arch Gen Psychiatry. 2003 Jul;60(7):681-90. doi: 10.1001/archpsyc.60.7.681.

引用本文的文献

1
Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals.进一步的证据表明,抗精神病药物并不能预防高风险个体的长期精神病。
Eur Arch Psychiatry Clin Neurosci. 2022 Jun;272(4):591-602. doi: 10.1007/s00406-021-01331-2. Epub 2021 Sep 18.
2
Long-term Efficacy and Tolerability of Perospirone for Young Help-seeking People at Clinical High Risk: a Preliminary Open Trial.首发精神病患者临床高风险人群中长期应用哌罗匹隆的疗效和耐受性:一项初步开放试验
Clin Psychopharmacol Neurosci. 2013 Dec;11(3):132-6. doi: 10.9758/cpn.2013.11.3.132. Epub 2013 Dec 24.
3
Antipsychotic interventions in prodromal psychosis: safety issues.
前驱期精神病的抗精神病干预:安全性问题。
CNS Drugs. 2013 Mar;27(3):197-205. doi: 10.1007/s40263-013-0046-1.
4
Evaluation and treatment of children and adolescents with psychotic symptoms.儿童和青少年精神病症状的评估和治疗。
Curr Psychiatry Rep. 2012 Apr;14(2):101-10. doi: 10.1007/s11920-012-0258-y.